- Full Year 2023 Medacta Group SA Earnings Call TranscriptMar 13, 2024$83.91Earnings
- Full Year 2023 Medacta Group SA Corporate Sales Call TranscriptFeb 02, 2024
- Half Year 2023 Medacta Group SA Earnings Call TranscriptSep 22, 2023$83.91Earnings
- Half Year 2023 Medacta Group SA Corporate Sales Call TranscriptJul 28, 2023
- Full Year 2022 Medacta Group SA Earnings Call TranscriptMar 17, 2023$83.91Earnings
- Q4 2022 Medacta Group SA Unaudited Top-Line Figures Call TranscriptFeb 03, 2023
- Half Year 2022 Medacta Group SA Earnings Call TranscriptSep 09, 2022$86.33Earnings
- Half Year 2022 Medacta Group SA Earnings Call TranscriptJul 29, 2022$86Earnings
- Full Year 2021 Medacta Group SA Earnings Call TranscriptMar 11, 2022$124Earnings
- Q4 2021 Medacta Group SA Corporate Sales Call TranscriptJan 20, 2022
- Half Year 2021 Medacta Group SA Earnings Call TranscriptSep 10, 2021$123.5Earnings
- Half Year 2021 Medacta Group SA Corporate Sales Call TranscriptJul 20, 2021
- Full Year 2020 Medacta Group SA Earnings Call TranscriptMar 31, 2021$114.6Earnings
- Full Year 2020 Medacta Group SA Corporate Sales Call TranscriptJan 21, 2021
- Half Year 2020 Medacta Group SA Earnings Call TranscriptSep 07, 2020Earnings
- Half Year 2020 Medacta Group SA Earnings Call TranscriptJul 22, 2020$65Earnings
- Full Year 2019 Medacta Group SA Earnings Call TranscriptApr 06, 2020Earnings
Half Year 2020 Medacta Group SA Earnings Call Transcript
Dear ladies and gentlemen, welcome to the conference call of Medacta Group SA. At our customer's request, this conference will be recorded. (Operator Instructions)
May I now hand you over to Medacta CEO, Mr. Francesco Siccardi, who will lead you through this conference. Please go ahead, sir.
Good afternoon, ladies and gentlemen, and thank you for joining Medacta's H1 unaudited top line figures. I will be presenting most of the slides today. And for the Q&A, I will be, together with Corrado Farsetta, able to answer any question you might have.
So if we go through the slides, we can, I think, jump after the disclosures, Corrado, on Slide #4. We have been, of course, affected during the H1 by the COVID situation. As we all know, this has caused elective surgeries to be deferred in many countries. The impact of these orthopedic surgeries deferral has been very different from country to country. And this clearly reflects on the differences across
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)